Table of Contents 1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered 1.4 Market Analysis by Type 1.4.1 Global Schizophrenia Therapeutics Market Size Growth Rate by Type (2014-2025) 1.4.2 First-Generation Antipsychotic Drugs 1.4.3 Second-Generation Antipsychotic Drugs 1.4.4 Third-Generation Antipsychotic Drugs 1.5 Market by Application 1.5.1 Global Schizophrenia Therapeutics Market Share by Application (2014-2025) 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Other 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Schizophrenia Therapeutics Market Size 2.2 Schizophrenia Therapeutics Growth Trends by Regions 2.2.1 Schizophrenia Therapeutics Market Size by Regions (2014-2025) 2.2.2 Schizophrenia Therapeutics Market Share by Regions (2014-2019) 2.3 Industry Trends 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Opportunities 3 Market Share by Key Players 3.1 Schizophrenia Therapeutics Market Size by Manufacturers 3.1.1 Global Schizophrenia Therapeutics Revenue by Manufacturers (2014-2019) 3.1.2 Global Schizophrenia Therapeutics Revenue Market Share by Manufacturers (2014-2019) 3.1.3 Global Schizophrenia Therapeutics Market Concentration Ratio (CR5 and HHI) 3.2 Schizophrenia Therapeutics Key Players Head office and Area Served 3.3 Key Players Schizophrenia Therapeutics Product/Solution/Service 3.4 Date of Enter into Schizophrenia Therapeutics Market 3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application 4.1 Global Schizophrenia Therapeutics Market Size by Type (2014-2019) 4.2 Global Schizophrenia Therapeutics Market Size by Application (2014-2019) 5 United States 5.1 United States Schizophrenia Therapeutics Market Size (2014-2019) 5.2 Schizophrenia Therapeutics Key Players in United States 5.3 United States Schizophrenia Therapeutics Market Size by Type 5.4 United States Schizophrenia Therapeutics Market Size by Application 6 Europe 6.1 Europe Schizophrenia Therapeutics Market Size (2014-2019) 6.2 Schizophrenia Therapeutics Key Players in Europe 6.3 Europe Schizophrenia Therapeutics Market Size by Type 6.4 Europe Schizophrenia Therapeutics Market Size by Application 7 China 7.1 China Schizophrenia Therapeutics Market Size (2014-2019) 7.2 Schizophrenia Therapeutics Key Players in China 7.3 China Schizophrenia Therapeutics Market Size by Type 7.4 China Schizophrenia Therapeutics Market Size by Application 8 Japan 8.1 Japan Schizophrenia Therapeutics Market Size (2014-2019) 8.2 Schizophrenia Therapeutics Key Players in Japan 8.3 Japan Schizophrenia Therapeutics Market Size by Type 8.4 Japan Schizophrenia Therapeutics Market Size by Application 9 Southeast Asia 9.1 Southeast Asia Schizophrenia Therapeutics Market Size (2014-2019) 9.2 Schizophrenia Therapeutics Key Players in Southeast Asia 9.3 Southeast Asia Schizophrenia Therapeutics Market Size by Type 9.4 Southeast Asia Schizophrenia Therapeutics Market Size by Application 10 India 10.1 India Schizophrenia Therapeutics Market Size (2014-2019) 10.2 Schizophrenia Therapeutics Key Players in India 10.3 India Schizophrenia Therapeutics Market Size by Type 10.4 India Schizophrenia Therapeutics Market Size by Application 11 Central & South America 11.1 Central & South America Schizophrenia Therapeutics Market Size (2014-2019) 11.2 Schizophrenia Therapeutics Key Players in Central & South America 11.3 Central & South America Schizophrenia Therapeutics Market Size by Type 11.4 Central & South America Schizophrenia Therapeutics Market Size by Application 12 International Players Profiles 12.1 AstraZeneca 12.1.1 AstraZeneca Company Details 12.1.2 Company Description and Business Overview 12.1.3 Schizophrenia Therapeutics Introduction 12.1.4 AstraZeneca Revenue in Schizophrenia Therapeutics Business (2014-2019) 12.1.5 AstraZeneca Recent Development 12.2 Eli Lilly 12.2.1 Eli Lilly Company Details 12.2.2 Company Description and Business Overview 12.2.3 Schizophrenia Therapeutics Introduction 12.2.4 Eli Lilly Revenue in Schizophrenia Therapeutics Business (2014-2019) 12.2.5 Eli Lilly Recent Development 12.3 GlaxoSmithKline 12.3.1 GlaxoSmithKline Company Details 12.3.2 Company Description and Business Overview 12.3.3 Schizophrenia Therapeutics Introduction 12.3.4 GlaxoSmithKline Revenue in Schizophrenia Therapeutics Business (2014-2019) 12.3.5 GlaxoSmithKline Recent Development 12.4 Johnson & Johnson 12.4.1 Johnson & Johnson Company Details 12.4.2 Company Description and Business Overview 12.4.3 Schizophrenia Therapeutics Introduction 12.4.4 Johnson & Johnson Revenue in Schizophrenia Therapeutics Business (2014-2019) 12.4.5 Johnson & Johnson Recent Development 12.5 Alkermes 12.5.1 Alkermes Company Details 12.5.2 Company Description and Business Overview 12.5.3 Schizophrenia Therapeutics Introduction 12.5.4 Alkermes Revenue in Schizophrenia Therapeutics Business (2014-2019) 12.5.5 Alkermes Recent Development 12.6 AbbVie 12.6.1 AbbVie Company Details 12.6.2 Company Description and Business Overview 12.6.3 Schizophrenia Therapeutics Introduction 12.6.4 AbbVie Revenue in Schizophrenia Therapeutics Business (2014-2019) 12.6.5 AbbVie Recent Development 12.7 Amgen 12.7.1 Amgen Company Details 12.7.2 Company Description and Business Overview 12.7.3 Schizophrenia Therapeutics Introduction 12.7.4 Amgen Revenue in Schizophrenia Therapeutics Business (2014-2019) 12.7.5 Amgen Recent Development 12.8 Bristol-Myers Squibb 12.8.1 Bristol-Myers Squibb Company Details 12.8.2 Company Description and Business Overview 12.8.3 Schizophrenia Therapeutics Introduction 12.8.4 Bristol-Myers Squibb Revenue in Schizophrenia Therapeutics Business (2014-2019) 12.8.5 Bristol-Myers Squibb Recent Development 13 Market Forecast 2019-2025 13.1 Market Size Forecast by Regions 13.2 United States 13.3 Europe 13.4 China 13.5 Japan 13.6 Southeast Asia 13.7 India 13.8 Central & South America 13.9 Market Size Forecast by Product (2019-2025) 13.10 Market Size Forecast by Application (2019-2025) 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.1.1 Research Programs/Design 15.1.1.2 Market Size Estimation 12.1.1.3 Market Breakdown and Data Triangulation 15.1.2 Data Source 15.1.2.1 Secondary Sources 15.1.2.2 Primary Sources 15.2 Disclaimer 15.3 Author Details

List of Tables and Figures Table Schizophrenia Therapeutics Key Market Segments Table Key Players Schizophrenia Therapeutics Covered Table Global Schizophrenia Therapeutics Market Size Growth Rate by Type 2014-2025 (Million US$) Figure Global Schizophrenia Therapeutics Market Size Market Share by Type 2014-2025 Figure First-Generation Antipsychotic Drugs Figures Table Key Players of First-Generation Antipsychotic Drugs Figure Second-Generation Antipsychotic Drugs Figures Table Key Players of Second-Generation Antipsychotic Drugs Figure Third-Generation Antipsychotic Drugs Figures Table Key Players of Third-Generation Antipsychotic Drugs Table Global Schizophrenia Therapeutics Market Size Growth by Application 2014-2025 (Million US$) Figure Hospitals Case Studies Figure Clinics Case Studies Figure Other Case Studies Figure Schizophrenia Therapeutics Report Years Considered Table Global Schizophrenia Therapeutics Market Size 2014-2025 (Million US$) Figure Global Schizophrenia Therapeutics Market Size and Growth Rate 2014-2025 (Million US$) Table Global Schizophrenia Therapeutics Market Size by Regions 2014-2025 (Million US$) Table Global Schizophrenia Therapeutics Market Size by Regions 2014-2019 (Million US$) Table Global Schizophrenia Therapeutics Market Share by Regions 2014-2019 Figure Global Schizophrenia Therapeutics Market Share by Regions 2014-2019 Figure Global Schizophrenia Therapeutics Market Share by Regions 2019 Table Market Top Trends Table Global Schizophrenia Therapeutics Revenue by Manufacturers (2014-2019) (Million US$) Table Global Schizophrenia Therapeutics Market Share by Manufacturers (2014-2019) Figure Global Schizophrenia Therapeutics Market Share by Manufacturers in 2018 Table Global Schizophrenia Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI) Table Key Players Head office and Area Served Table Key Players Schizophrenia Therapeutics Product/Solution/Service Table Date of Enter into Schizophrenia Therapeutics Market Table Mergers & Acquisitions, Expansion Plans Table Global Schizophrenia Therapeutics Market Size by Type (2014-2019) (Million US$) Table Global Schizophrenia Therapeutics Market Size Share by Type (2014-2019) Figure Global Schizophrenia Therapeutics Market Size Market Share by Type (2014-2019) Table Global Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$) Table Global Schizophrenia Therapeutics Market Size Share by Application (2014-2019) Figure Global Schizophrenia Therapeutics Market Size Market Share by Application (2014-2019) Figure Global Schizophrenia Therapeutics Revenue Market Share by Application in 2018 Figure United States Schizophrenia Therapeutics Market Size 2014-2019 (Million US$) Table United States Key Players Schizophrenia Therapeutics Revenue (2018-2019) (Million US$) Table United States Key Players Schizophrenia Therapeutics Market Share (2018-2019) Table United States Schizophrenia Therapeutics Market Size by Type (2014-2019) (Million US$) Table United States Schizophrenia Therapeutics Market Share by Type (2014-2019) Table United States Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$) Table United States Schizophrenia Therapeutics Market Share by Application (2014-2019) Figure Europe Schizophrenia Therapeutics Market Size 2014-2019 (Million US$) Table Europe Key Players Schizophrenia Therapeutics Revenue (2018-2019) (Million US$) Table Europe Key Players Schizophrenia Therapeutics Market Share (2018-2019) Table Europe Schizophrenia Therapeutics Market Size by Type (2014-2019) (Million US$) Table Europe Schizophrenia Therapeutics Market Share by Type (2014-2019) Table Europe Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$) Table Europe Schizophrenia Therapeutics Market Share by Application (2014-2019) Figure China Schizophrenia Therapeutics Market Size 2014-2019 (Million US$) Table China Key Players Schizophrenia Therapeutics Revenue (2018-2019) (Million US$) Table China Key Players Schizophrenia Therapeutics Market Share (2018-2019) Table China Schizophrenia Therapeutics Market Size by Type (2014-20189) (Million US$) Table China Schizophrenia Therapeutics Market Share by Type (2014-2019) Table China Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$) Table China Schizophrenia Therapeutics Market Share by Application (2014-2019) Figure Japan Schizophrenia Therapeutics Market Size 2014-2019 (Million US$) Table Japan Key Players Schizophrenia Therapeutics Revenue (2018-2019) (Million US$) Table Japan Key Players Schizophrenia Therapeutics Market Share (2018-2019) Table Japan Schizophrenia Therapeutics Market Size by Type (2014-2019) (Million US$) Table Japan Schizophrenia Therapeutics Market Share by Type (2014-2019) Table Japan Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$) Table Japan Schizophrenia Therapeutics Market Share by Application (2014-2019) Figure Southeast Asia Schizophrenia Therapeutics Market Size 2014-2019 (Million US$) Table Southeast Asia Key Players Schizophrenia Therapeutics Revenue (2018-2019) (Million US$) Table Southeast Asia Key Players Schizophrenia Therapeutics Market Share (2018-2019) Table Southeast Asia Schizophrenia Therapeutics Market Size by Type (2014-2019) (Million US$) Table Southeast Asia Schizophrenia Therapeutics Market Share by Type (2014-2019) Table Southeast Asia Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$) Table Southeast Asia Schizophrenia Therapeutics Market Share by Application (2014-2019) Figure India Schizophrenia Therapeutics Market Size 2014-2019 (Million US$) Table India Key Players Schizophrenia Therapeutics Revenue (2018-2019) (Million US$) Table India Key Players Schizophrenia Therapeutics Market Share (2018-2019) Table India Schizophrenia Therapeutics Market Size by Type (2014-2019) (Million US$) Table India Schizophrenia Therapeutics Market Share by Type (2014-2019) Table India Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$) Table India Schizophrenia Therapeutics Market Share by Application (2014-2019) Figure Central & South America Schizophrenia Therapeutics Market Size 2014-2019 (Million US$) Table Central & South America Key Players Schizophrenia Therapeutics Revenue (2018-2019) (Million US$) Table Central & South America Key Players Schizophrenia Therapeutics Market Share (2018-2019) Table Central & South America Schizophrenia Therapeutics Market Size by Type (2014-2019) (Million US$) Table Central & South America Schizophrenia Therapeutics Market Share by Type (2014-2019) Table Central & South America Schizophrenia Therapeutics Market Size by Application (2014-2019) (Million US$) Table Central & South America Schizophrenia Therapeutics Market Share by Application (2014-2019) Table AstraZeneca Company Details Table AstraZeneca Revenue in Schizophrenia Therapeutics Business (2014-2019) (Million US$) Figure AstraZeneca Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019) Table AstraZeneca Recent Development Table Eli Lilly Company Details Table Eli Lilly Revenue in Schizophrenia Therapeutics Business (2014-2019)(Million US$) Figure Eli Lilly Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019) Table Eli Lilly Recent Development Table GlaxoSmithKline Company Details Table GlaxoSmithKline Revenue in Schizophrenia Therapeutics Business (2014-2019)(Million US$) Figure GlaxoSmithKline Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019) Table GlaxoSmithKline Recent Development Table Johnson & Johnson Company Details Table Johnson & Johnson Revenue in Schizophrenia Therapeutics Business (2014-2019)(Million US$) Figure Johnson & Johnson Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019) Table Johnson & Johnson Recent Development Table Alkermes Company Details Table Alkermes Revenue in Schizophrenia Therapeutics Business (2014-2019)(Million US$) Figure Alkermes Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019) Table Alkermes Recent Development Table AbbVie Company Details Table AbbVie Revenue in Schizophrenia Therapeutics Business (2014-2019)(Million US$) Figure AbbVie Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019) Table AbbVie Recent Development Table Amgen Company Details Table Amgen Revenue in Schizophrenia Therapeutics Business (2014-2019)(Million US$) Figure Amgen Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019) Table Amgen Recent Development Table Bristol-Myers Squibb Company Details Table Bristol-Myers Squibb Revenue in Schizophrenia Therapeutics Business (2014-2019)(Million US$) Figure Bristol-Myers Squibb Revenue Growth Rate in Schizophrenia Therapeutics Business (2014-2019) Table Bristol-Myers Squibb Recent Development Table Global Schizophrenia Therapeutics Market Size by Regions (Million US$) 2019-2025 Figure Global Schizophrenia Therapeutics Market Size Share by Regions (2019-2025) Figure Global Schizophrenia Therapeutics Market Size Share by Regions in 2025 Figure United States Schizophrenia Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Europe Schizophrenia Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure China Schizophrenia Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Japan Schizophrenia Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Southeast Asia Schizophrenia Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure India Schizophrenia Therapeutics Market Size Forecast (2019-2025)(Million USD) Figure Central & South America Schizophrenia Therapeutics Market Size Forecast (2019-2025)(Million USD) Table Global Schizophrenia Therapeutics Market Size by Product (2019-2025) (Million US$) Figure Global Schizophrenia Therapeutics Market Size by Product (2019-2025) Figure Global Schizophrenia Therapeutics Market Size by Product in 2025 Table Global Schizophrenia Therapeutics Market Size by Application (2019-2025) (Million US$) Figure Global Schizophrenia Therapeutics Market Size by Application (2019-2025) Figure Global Schizophrenia Therapeutics Market Size by Application in 2025 Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

AstraZeneca Eli Lilly GlaxoSmithKline Johnson & Johnson Alkermes AbbVie Amgen Bristol-Myers Squibb